Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Cloud DX secures C$770,000 order for vital sign monitoring system Vitaliti

Cloud DX (TSX-V:CDX, OTCQB:CDXFF) announced that it has received a purchase order for up to 300 of its advanced Vitaliti continuous vital sign monitor (CVSM) systems and related software valued at C$770,000.

Each Vitaliti system is made up of a main unit that attaches to the chest, ECG leads and an earpiece with multiple sensors allowing for the measurement of the patient’s vital signs, including their pulse oxygen, heart rate, respiration rate, and core body temperature.

The units will be manufactured at the company’s Kitchener, Ontario facility and are expected to be delivered by the end of the second quarter of 2024.

Cloud DX (TSX-V:CDX, OTCQB:CDXFF) will receive a 50% deposit for the order with the balance to be paid upon delivery of the units.

The company said that the Vitaliti units are set to be deployed in multi-site studies involving post-operative patients, the first being carried out under a Health Canada Investigational Testing Authorization (ITA) ahead of full Health Canada and US Food and Drug Administration (FDA) clearance.

The patients will be tracked at home following their surgeries and the data collected by the units will be used to train generative artificial intelligence (AI) algorithms that are expected to be able to predict and avoid adverse outcomes.

Cloud DX CEO Robert Kaul said that this initial order for advanced Vitaliti CVSM systems was an important milestone for Cloud DX.

“We first introduced Vitaliti as the core element of our XPRIZE-winning Tricorder in 2017. We then went back to a clean sheet of paper and re-designed Vitaliti to become one of the most accurate and effective continuous vital sign monitor solutions in the world,” he said.

“This first deployment of Vitaliti in a highly-regarded, multi-site, multi-year clinical study will move forward the state of the art in virtual care while also gathering data required for Health Canada and FDA regulatory approvals."

The company highlighted that in the year to date, Cloud DX has announced seven contracts valued at more than C$2.5 million, including with Health PEI, Markham Stouffville Hospital and VHA Home Healthcare.

Cloud DX is on a mission to make healthcare better for everyone. Its Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable aging in place, and deliver hospital-quality post-surgical care in the home.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK